The ADAM17 substrates Nectin-4 and HB-EGF appear to be promising markers for the detection of early stages of ovarian cancer and are associated with prognostically favorable parameters, such as early FIGO stage and successful tumor debulking. This evidence concerns the gene ADAM17 and ovarian cancer.